Riskpilot← Back to searchSign inGet full accessSpectoceutics ApS
APSActiveCVR 44427923Solbakkevej 37AResearch and experimental development on natural sciences and engineering · NACE 7210Est. 2023— employees
Revenue 2024
DKK -7K
EBITDA margin
100.0%
Equity ratio
97.7%
Financial strength
Net profit 2024
DKK -7K
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Dunnock Holding ApS
Spectoceutics ApS